Oxford and GSK launch £50m programme to advance cancer research
Global biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer.
Read moreLatest News
Upcoming Talks
Deciphering the gene regulation of oxygen homeostasis and human fitness through the lens of erythropoietin producing Norn cells
Tuesday, 07 July 2026, 2.30pm to 3.30pm
Status: Cancelled
The architecture, assembly, and evolution of a complex flagellar motor
Friday, 10 July 2026, 11am to 12pm
OxON-14: Targeting Synapse Loss to Rescue Memory in Alzheimer’s Disease
Friday, 10 July 2026, 12pm to 1pm
Latest publications
The double-edged nature of antibody bivalency: mathematical and experimental analysis of cell surface antigen occupancy and opsonization.
Journal article
Heirene L. et al, (2026), MAbs, 18
DNA prime and peptide boost immunization elicits robust neoantigen-specific CD8 + T cell responses and therapeutic protection in mouse tumor models.
Journal article
Morgado-Cáceres P. et al, (2026), Oncoimmunology, 15
Ginkgo Datapoints Antibody Developability Competition outcomes: limited model performance and a call for data standardization.
Journal article
van Niekerk L. et al, (2026), MAbs, 18
Systematic review and data-driven insights into CHO cell engineering for next-generation antibody production.
Journal article
Schulz A. et al, (2026), MAbs, 18